{"component": "definition", "props": {"groups": [{"size": 4, "snippet_links": [{"key": "pursuant-to-paragraph", "type": "clause", "offset": [239, 260]}], "samples": [{"hash": "e6qOYr8I4XS", "uri": "https://rx-360.org/wp-content/uploads/2018/08/Ranbaxy-consent-decree-agreement.pdf", "label": "rx-360.org", "score": 8.1389459274, "published": false}, {"hash": "2robH96jnmJ", "uri": "https://hbw.citeline.com/-/media/pmbi-old-site/supporting-documents/the-pink-sheet-daily/2012/ranbaxyconsentdecree.pdf", "label": "hbw.citeline.com", "score": 6.0321697467, "published": false}, {"hash": "hYmokg0lypv", "uri": "https://www.modernhealthcare.com/assets/pdf/CH77366126.PDF", "label": "www.modernhealthcare.com", "score": 5.9815195072, "published": false}], "snippet": "means: (1) Ranbaxy Laboratories, Ltd., Sirmour District, Himanchal Pradesh, India (hereafter, \u201cPaonta Sahib\u201d); (2) Ranbaxy Laboratories, Ltd., Industrial Area-3, Dewas, India (hereafter, \u201cDewas\u201d); and (3) any facility added to this Decree pursuant to paragraph XXIX. Defendant Ranbaxy Laboratories, Ltd. has represented to FDA and now", "hash": "1df76391c445f97c31801da74566dc1b", "id": 1}, {"size": 4, "snippet_links": [{"key": "offshore-facility", "type": "definition", "offset": [9, 26]}, {"key": "located-in", "type": "definition", "offset": [27, 37]}, {"key": "state-waters", "type": "definition", "offset": [38, 50]}, {"key": "the-state", "type": "clause", "offset": [158, 167]}], "samples": [{"hash": "cMfj5Z51b6U", "uri": "/contracts/cMfj5Z51b6U#covered-facilities", "label": "Memorandum of Understanding", "score": 29.2425880785, "published": true}, {"hash": "1IIRqONegfT", "uri": "/contracts/1IIRqONegfT#covered-facilities", "label": "Memorandum of Understanding", "score": 29.2206872054, "published": true}, {"hash": "6UQUplsBsbv", "uri": "/contracts/6UQUplsBsbv#covered-facilities", "label": "Memorandum of Understanding", "score": 29.1960487231, "published": true}], "snippet": "means an offshore facility located in State waters seaward of the coast line that handles, stores, or transports oil or gas and is regulated by both BSEE and the State.", "hash": "c0ccfdbd96857b9348820ed91c4d1093", "id": 2}, {"size": 3, "snippet_links": [], "samples": [{"hash": "9YX0C6BYQGQ", "uri": "https://www.epa.gov/sites/production/files/2018-04/documents/markwest-cd.pdf", "label": "www.epa.gov", "score": 9.1396303901, "published": false}, {"hash": "94JbE6hiLzf", "uri": "http://www.awma-rmss.org/wp-content/uploads/markwest-cd-002.pdf", "label": "www.awma-rmss.org", "score": 9.1396303901, "published": false}, {"hash": "4TaXoU1FzmA", "uri": "https://www.justice.gov/enrd/consent-decree/file/1056706/dl", "label": "www.justice.gov", "score": 7.1396303901, "published": false}], "snippet": "means all MarkWest facilities identified in Appendices 1-5.", "hash": "74ebd70f9b9712a7a765495a1fab8dad", "id": 3}, {"size": 3, "snippet_links": [{"key": "the-facilities", "type": "clause", "offset": [6, 20]}, {"key": "on-schedule", "type": "definition", "offset": [31, 42]}], "samples": [{"hash": "i3cl1sd45PX", "uri": "/contracts/i3cl1sd45PX#covered-facilities", "label": "Asset Purchase Agreement (Portola Pharmaceuticals Inc)", "score": 24.2772073922, "published": true}, {"hash": "fyBICWGpb7b", "uri": "/contracts/fyBICWGpb7b#covered-facilities", "label": "Asset Purchase Agreement (Portola Pharmaceuticals Inc)", "score": 23.970568104, "published": true}], "snippet": "means the facilities described on Schedule A.", "hash": "5d8cf0133628012eeaab318acf61f05c", "id": 4}, {"size": 2, "snippet_links": [], "samples": [{"hash": "ghnpKnsqPpu", "uri": "https://www.epa.gov/sites/production/files/2013-09/documents/equistarchemicals-cd.pdf", "label": "www.epa.gov", "score": 3.0, "published": false}, {"hash": "1WsfP0BrbJh", "uri": "https://19january2021snapshot.epa.gov/sites/static/files/documents/equistarchemicals-cd.pdf", "label": "19january2021snapshot.epa.gov", "score": 3.0, "published": false}], "snippet": "means the following areas of the plants owned/leased and operated by Equistar or affiliates:", "hash": "d148294f9810686ca1927a8c68ed3711", "id": 5}, {"size": 2, "snippet_links": [{"key": "processing-plants", "type": "definition", "offset": [43, 60]}, {"key": "owned-and-operated", "type": "definition", "offset": [61, 79]}], "samples": [{"hash": "cOxISFEcAOJ", "uri": "https://www.justice.gov/enrd/consent-decree/file/1580646/dl", "label": "www.justice.gov", "score": 16.2155840013, "published": false}, {"hash": "6aNHTRwooAm", "uri": "https://www.epa.gov/system/files/documents/2023-04/wesdjgatheringllc-cd_0.pdf", "label": "www.epa.gov", "score": 11.6488706366, "published": false}], "snippet": "means, collectively, the three natural gas processing plants owned and operated by WDJG near Fort Lupton, Colorado known as the Platte Valley, Lancaster, and Fort Lupton Plants.", "hash": "2561e3ae3ca28dee0a10828ef142c157", "id": 6}, {"size": 2, "snippet_links": [{"key": "in-section-2", "type": "clause", "offset": [33, 45]}], "samples": [{"hash": "amd4BObvEZ4", "uri": "/contracts/amd4BObvEZ4#covered-facilities", "label": "Telecommunications Network Access Agreement (Boingo Wireless Inc)", "score": 22.3223819302, "published": true}, {"hash": "iy6pXbhR1Rh", "uri": "/contracts/iy6pXbhR1Rh#covered-facilities", "label": "Telecommunications Network Access Agreement (Boingo Wireless Inc)", "score": 22.1498973306, "published": true}], "snippet": "shall have the meaning set forth in Section 2.", "hash": "90ae58f8e23ccd32b83b27070dfb99fc", "id": 7}, {"size": 2, "snippet_links": [{"key": "the-preamble", "type": "clause", "offset": [36, 48]}], "samples": [{"hash": "j9wG63LmoVC", "uri": "/contracts/j9wG63LmoVC#covered-facilities", "label": "Merger Agreement (Fly Leasing LTD)", "score": 32.241615332, "published": true}, {"hash": "bdAZfj1UAhw", "uri": "/contracts/bdAZfj1UAhw#covered-facilities", "label": "Sub Servicing Agreement (Fly Leasing LTD)", "score": 32.241615332, "published": true}], "snippet": "shall have the meaning set forth in the preamble.", "hash": "74fef11c12a7046b6c9003b8066569d0", "id": 8}, {"size": 2, "snippet_links": [], "samples": [{"hash": "fS31eW0KK5M", "uri": "/contracts/fS31eW0KK5M#covered-facilities", "label": "Purchase Agreement (Dresser Inc)", "score": 21.0, "published": true}, {"hash": "b2U7QS1gEUd", "uri": "/contracts/b2U7QS1gEUd#covered-facilities", "label": "Purchase Agreement (Cooper Cameron Corp)", "score": 21.0, "published": true}], "snippet": "shall have the meaning set forth in Section 7.03(b).", "hash": "22f91a847267ba207f3c0b0ba8da2fc3", "id": 9}, {"size": 2, "snippet_links": [{"key": "owned-and-operated", "type": "definition", "offset": [40, 58]}], "samples": [{"hash": "lng5JjBwU8g", "uri": "https://elr.info/sites/default/files/doj-consent-decrees/r_sabicinnovativeplasticsconsentdecree2012final.pdf_-_adobe_acrobat_pro.pdf", "label": "elr.info", "score": 4.2060232717, "published": false}, {"hash": "1DaAOioMLOl", "uri": "https://www.epa.gov/sites/production/files/documents/sabic-cd.pdf", "label": "www.epa.gov", "score": 4.2032854209, "published": false}], "snippet": "means the following facilities that are owned and operated by SABIC US and SABIC MTV, respectively:", "hash": "2c91560e12fe8441335b368e9d9bdab8", "id": 10}], "next_curs": "Cl8SWWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjsLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIbY292ZXJlZC1mYWNpbGl0aWVzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 45, "title": "Covered Facilities", "snippet": "means: (1) Ranbaxy Laboratories, Ltd., Sirmour District, Himanchal Pradesh, India (hereafter, \u201cPaonta Sahib\u201d); (2) Ranbaxy Laboratories, Ltd., Industrial Area-3, Dewas, India (hereafter, \u201cDewas\u201d); and (3) any facility added to this Decree pursuant to paragraph XXIX. Defendant Ranbaxy Laboratories, Ltd. has represented to FDA and now", "id": "covered-facilities", "examples": ["Each Party shall cooperate with, and support efforts by, <strong>Covered Facilities</strong> to operate in a way to avoid a determination of a Denial of Rights.", "The Facility Compliance Officers shall be responsible for implementing policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and with Federal health care program requirements for the <strong>Covered Facilities</strong>, and shall monitor the day-to-day compliance activities of the <strong>Covered Facilities</strong>.", "The Facility Compliance Committees shall be maintained for the duration of the CIA and shall include appropriate personnel and other members of senior management at each of CHSI\u2019s <strong>Covered Facilities</strong> necessary to meet the requirements of this CIA (e.g., senior executives of relevant departments, such as billing, clinical, human resources, audit, and operations).", "MSRC may periodically provide to the COMPANY MSRC&#x27;s current list of Covered Entities, <strong>Covered Facilities</strong> and Covered Vessels, and Authorized Representatives, which the COMPANY will review, correct, and return promptly to MSRC.", "Upon the COMPANY&#x27;s execution of this Agreement and from time to time afterwards, the COMPANY will provide MSRC with an accurate list of all Covered Entities and their addresses, and all <strong>Covered Facilities</strong> and Covered Vessels of each Covered Entity that intend to identify Resources in their Response Plans.", "The Inpatient Medical Necessity and Appropriateness Review shall be conducted at 7.5% of CHSI\u2019s <strong>Covered Facilities</strong> for each Reporting Period.", "Within 30 days after OIG receives the IRO\u2019s recommendations, OIG will notify CHSI and the IRO if the recommendations are unacceptable and provide a final list of <strong>Covered Facilities</strong> to be reviewed and the schedule of reviews.", "In addition, within 60 days after the end of each Reporting Period, the IRO shall provide OIG with its recommendations of the <strong>Covered Facilities</strong> to be reviewed for the Reporting Period.", "The Population shall be defined as all Paid Claims at the selected <strong>Covered Facilities</strong> during the 12-month period covered by the Claims Review.", "The IRO shall review CHSI <strong>Covered Facilities</strong> coding, billing, and claims submission to the Federal health care programs and the reimbursement received (Inpatient Medical Necessity and Appropriateness Review) and shall prepare an Inpatient Medical Necessity and Appropriateness Review Report, as outlined in Appendix B to this CIA, which is incorporated by reference."], "related": [["shared-facilities", "Shared Facilities", "Shared Facilities"], ["railroad-facilities", "Railroad facilities", "Railroad facilities"], ["generating-facilities", "Generating Facilities", "Generating Facilities"], ["permitted-facility", "Permitted Facility", "Permitted Facility"], ["common-areas-and-facilities", "Common Areas and Facilities", "Common Areas and Facilities"]], "related_snippets": [], "updated": "2025-07-06T21:58:41+00:00"}, "json": true, "cursor": ""}}